Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
- PMID: 39837324
- PMCID: PMC11925689
- DOI: 10.1016/j.neuron.2024.12.026
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
Abstract
Gliomas are aggressive neoplasms that diffusely infiltrate the brain and cause neurological symptoms, including cognitive deficits and seizures. Increased mTOR signaling has been implicated in glioma-induced neuronal hyperexcitability, but the molecular and functional consequences have not been identified. Here, we show three types of changes in tumor-associated neurons: (1) downregulation of transcripts encoding excitatory and inhibitory postsynaptic proteins and dendritic spine development and upregulation of cytoskeletal transcripts via neuron-specific profiling of ribosome-bound mRNA, (2) marked decreases in dendritic spine density via light and electron microscopy, and (3) progressive functional alterations leading to neuronal hyperexcitability via in vivo calcium imaging. A single acute dose of AZD8055, a combined mTORC1/2 inhibitor, reversed these tumor-induced changes. These findings reveal mTOR-driven pathological plasticity in neurons at the infiltrative margin of glioma and suggest new strategies for treating glioma-associated neurological symptoms.
Keywords: alterations in neuronal activity; brain tumor microenvironment; brain tumors; dendritic spines; excitatory neurons; glioma; glioma microenvironment; glioma-associated neuronal alterations; glioma-induced plasticity; mTOR inhibition; neuronal hyperexcitability.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors have declared no competing interests.
Update of
-
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.bioRxiv [Preprint]. 2024 Jan 21:2024.01.10.575092. doi: 10.1101/2024.01.10.575092. bioRxiv. 2024. Update in: Neuron. 2025 Mar 19;113(6):858-875.e10. doi: 10.1016/j.neuron.2024.12.026. PMID: 38293120 Free PMC article. Updated. Preprint.
Similar articles
-
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.bioRxiv [Preprint]. 2024 Jan 21:2024.01.10.575092. doi: 10.1101/2024.01.10.575092. bioRxiv. 2024. Update in: Neuron. 2025 Mar 19;113(6):858-875.e10. doi: 10.1016/j.neuron.2024.12.026. PMID: 38293120 Free PMC article. Updated. Preprint.
-
Phenotypic rescue via mTOR inhibition in neuron-specific Pten knockout mice reveals AKT and mTORC1-site specific changes.Mol Psychiatry. 2025 Jul;30(7):3077-3089. doi: 10.1038/s41380-025-02916-2. Epub 2025 Feb 14. Mol Psychiatry. 2025. PMID: 39953287
-
Instability of excitatory synapses in experimental autoimmune encephalomyelitis and the outcome for excitatory circuit inputs to individual cortical neurons.Brain Behav Immun. 2024 Jul;119:251-260. doi: 10.1016/j.bbi.2024.03.039. Epub 2024 Mar 27. Brain Behav Immun. 2024. PMID: 38552924 Free PMC article.
-
The mTOR pathway in Gliomas: From molecular insights to targeted therapies.Biomed Pharmacother. 2025 Aug;189:118237. doi: 10.1016/j.biopha.2025.118237. Epub 2025 Jun 21. Biomed Pharmacother. 2025. PMID: 40544748 Review.
-
Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.Nitric Oxide. 2023 Sep 1;138-139:10-16. doi: 10.1016/j.niox.2023.06.002. Epub 2023 Jun 4. Nitric Oxide. 2023. PMID: 37279819
Cited by
-
Aperiodic neural dynamics define a novel signature of glioma-induced excitation-inhibition dysregulation.bioRxiv [Preprint]. 2025 May 24:2025.05.23.655626. doi: 10.1101/2025.05.23.655626. bioRxiv. 2025. PMID: 40475422 Free PMC article. Preprint.
References
-
- Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, and Heimans JJ (2003). Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54, 514–520. 10.1002/ana.10712. - DOI - PubMed
MeSH terms
Substances
Grants and funding
- R01 CA244780/CA/NCI NIH HHS/United States
- F30 CA257768/CA/NCI NIH HHS/United States
- R01 NS118513/NS/NINDS NIH HHS/United States
- R01 NS084142/NS/NINDS NIH HHS/United States
- R01 NS063226/NS/NINDS NIH HHS/United States
- T32 GM145440/GM/NIGMS NIH HHS/United States
- P30 CA013696/CA/NCI NIH HHS/United States
- U24 NS120055/NS/NINDS NIH HHS/United States
- R61 CA278402/CA/NCI NIH HHS/United States
- K08 NS116166/NS/NINDS NIH HHS/United States
- P30 CA196521/CA/NCI NIH HHS/United States
- U54 CA274504/CA/NCI NIH HHS/United States
- R03 NS090151/NS/NINDS NIH HHS/United States
- F30 CA288006/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous